Top

Journal of Cancer Survivorship

Published in:

Open Access 01-06-2013

Investigating efficacy of two brief mind–body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial

Authors: Yoshio Nakamura, David L. Lipschitz, Renee Kuhn, Anita Y. Kinney, Gary W. Donaldson

Published in: Journal of Cancer Survivorship | Issue 2/2013

Abstract

Purpose

After completing treatment, cancer survivors may suffer from a multitude of physical and mental health impairments, resulting in compromised quality of life. This exploratory study investigated whether two mind–body interventions, i.e., Mind–Body Bridging (MBB) and Mindfulness Meditation (MM), could improve posttreatment cancer survivors’ self-reported sleep disturbance and comorbid symptoms, as compared to sleep hygiene education (SHE) as an active control.

Methods

This randomized controlled trial examined 57 cancer survivors with clinically significant self-reported sleep disturbance, randomly assigned to receive MBB, MM, or SHE. All interventions were conducted in three sessions, once per week. Patient-reported outcomes were assessed via the Medical Outcomes Study Sleep Scale and other indicators of psychosocial functioning relevant to quality of life, stress, depression, mindfulness, self-compassion, and well-being.

Results

Mixed effects model analysis revealed that mean sleep disturbance symptoms in the MBB (p = .0029) and MM (p = .0499) groups were lower than in the SHE group, indicating that both mind–body interventions improved sleep. In addition, compared with the SHE group, the MBB group showed reductions in self-reported depression symptoms (p = .040) and improvements in overall levels of mindfulness (p = .018), self-compassion (p = .028), and well-being (p = .019) at postintervention.

Conclusions

This study provides preliminary evidence that brief sleep-focused MBB and MM are promising interventions for sleep disturbance in cancer survivors. Integrating MBB or MM into posttreatment supportive plans should enhance care of cancer survivors with sleep disturbance. Because MBB produced additional secondary benefits, MBB may serve as a promising multipurpose intervention for posttreatment cancer survivors suffering from sleep disturbance and other comorbid symptoms.

Implications for Cancer Survivors

Two brief sleep-focused mind–body interventions investigated in the study were effective in reducing sleep disturbance and one of them further improved other psychosocial aspects of the cancer survivors’ life. Management of sleep problems in survivors is a high priority issue that demands more attention in cancer survivorship.

Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26(6):971–82.PubMedCrossRef

Ancoli-Israel S. Recognition and treatment of sleep disturbances in cancer. J Clin Oncol. 2009;27(35):5864–6.PubMedCrossRef

Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008;26(5):768–77.PubMedCrossRef

Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19(3):895–908.PubMed

Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24(5):583–90.PubMed

Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symp Manag. 1995;10(6):423–31.CrossRef

Shapiro SL, Bootzin RR, Figueredo AJ, Lopez AM, Schwartz GE. The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J Psychosom Res. 2003;54(1):85–91.PubMedCrossRef

Kvale EA, Shuster JL. Sleep disturbance in supportive care of cancer: a review. J Palliat Med. 2006;9(2):437–50. doi:10.1089/jpm.2006.9.437.PubMedCrossRef

Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind–body medicine: state of the science, implications for practice. J Am Board Fam Pract. 2003;16(2):131–47.PubMedCrossRef

10.

Begley S. Train your mind, change your brain: how a new science reveals our extraordinary potential to transform ourselves. New York: Ballantine; 2007.

11.

Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol. 2006;62(3):373–86. doi:10.1002/jclp.20237.PubMedCrossRef

12.

Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatr. 1982;4(1):33–47.CrossRef

13.

Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8(2):163–90.PubMedCrossRef

14.

Teasdale JD, Moore RG, Hayhurst H, Pope M, Williams S, Segal ZV. Metacognitive awareness and prevention of relapse in depression: empirical evidence. J Consult Clin Psychol. 2002;70(2):275–87.PubMedCrossRef

15.

Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000;68(4):615–23.PubMedCrossRef

16.

Block SH, Block CB. Come to your senses: demystifying the mind–body connection. 2nd ed. New York: Atria Books–Beyond Words; 2007.

17.

Shapiro SL, Carlson LE. The art and science of mindfulness: integrating mindfulness into psychology and the helping professions. American Psychological Association, D.C.; 2009.

18.

Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12(4):278–85.PubMedCrossRef

19.

Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003;65(4):571–81.PubMedCrossRef

20.

Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29(4):448–74.PubMedCrossRef

21.

Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho Oncol. 2009;18(12):1261–72.CrossRef

22.

Lengacher CA, Reich RR, Post-White J, Moscoso M, Shelton MM, Barta M, et al. Mindfulness based stress reduction in post-treatment breast cancer patients: an examination of symptoms and symptom clusters. J Behav Med. 2012;35(1):86–94. doi:10.1007/s10865-011-9346-4.PubMedCrossRef

23.

Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hebert JR. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Canc Res Treat. 2012;131(1):99–109. doi:10.1007/s10549-011-1738-1.CrossRef

24.

Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol. 2012;30(12):1335–42. doi:10.1200/JCO.2010.34.0331.PubMedCrossRef

25.

Lerman R, Jarski R, Rea H, Rea H, Gellish R, Vicini F, Vicini F. Improving symptoms and quality of life of female cancer survivors: a randomized controlled study. Ann Surg Oncol. 2012;19(2):373–8. doi:10.1245/s10434-011-2051-2.PubMedCrossRef

26.

Greene PB, Philip EJ, Poppito SR, Schnur JB. Mindfulness and psychosocial care in cancer: historical context and review of current and potential applications. Palliat Support Care. 2012. doi:10.1017/S1478951511001015.

27.

Piet J, Wurtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012. doi:10.1037/a0028329.

28.

Stan DL, Collins NM, Olsen MM, Croghan I, Pruthi S. The evolution of mindfulness-based physical interventions in breast cancer survivors. Evid Base Compl Alternative Med. 2012;2012:758641. doi:10.1155/2012/758641.

29.

Zainal NZ, Booth S, Huppert FA. The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psycho Oncol. 2012. doi:10.1002/pon.3171.

30.

Winbush NY, Gross CR, Kreitzer MJ. The effects of mindfulness-based stress reduction on sleep disturbance: a systematic review. Explore (NY). 2007;3(6):585–91.CrossRef

31.

Gross CR, Kreitzer MJ, Reilly-Spong M, Wall M, Winbush NY, Patterson R, et al. Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial. Explore (NY). 2011;7(2):76–87. doi:10.1016/j.explore.2010.12.003.CrossRef

32.

Britton WB, Haynes PL, Fridel KW, Bootzin RR. Polysomnographic and subjective profiles of sleep continuity before and after mindfulness-based cognitive therapy in partially remitted depression. Psychosom Med. 2010;72:539–48. doi:10.1097/PSY.0b013e3181dc1bad.PubMedCrossRef

33.

Nakamura Y, Lipschitz DL, Landward R, Kuhn R, West G. Two sessions of sleep-focused mind–body bridging improve self-reported symptoms of sleep and PTSD in veterans: A pilot randomized controlled trial. J Psychosom Res. 2011;70(4):335–45. doi:10.1016/j.jpsychores.2010.09.007.PubMedCrossRef

34.

Chiesa A, Serretti A. A systematic review of neurobiological and clinical features of mindfulness meditations. Psychol Med. 2010;40(8):1239–52. doi:10.1017/S0033291709991747.PubMedCrossRef

35.

Tollefson DR, Webb K, Shumway D, Block SH, Nakamura Y. A mind–body approach to domestic violence perpetrator treatment: program overview and preliminary outcomes. J Aggression Maltreat Trauma. 2009;18:17–45.CrossRef

36.

Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from stage I. Clin Psychol Sci Pract. 2001;8(2):133–42.CrossRef

37.

Bloom JR, Petersen DM, Kang SH. Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psycho Oncol. 2007;16(8):691–706. doi:10.1002/pon.1208.CrossRef

38.

Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s Studies of Cancer Survivors. Cancer. 2011;117(12):2779–90. doi:10.1002/cncr.26146.PubMedCrossRef

39.

Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6(1):41–4. doi:10.1016/j.sleep.2004.07.006.PubMedCrossRef

40.

Kabat-Zinn J. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness. New York: Delta; 1991.

41.

Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res. 2004;57(1):35–43. doi:10.1016/S0022-3999(03)00573-7.PubMedCrossRef

42.

Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53.PubMed

43.

Thomas KS, Bower J, Hoyt MA, Sepah S. Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psycho Oncol. 2010;19(7):767–76. doi:10.1002/pon.1639.CrossRef

44.

Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed

45.

Helgeson VS, Tomich PL. Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psycho Oncol. 2005;14(4):307–17. doi:10.1002/pon.848.CrossRef

46.

Tomich PL, Helgeson VS. Five years later: a cross-sectional comparison of breast cancer survivors with healthy women. Psycho Oncol. 2002;11(2):154–69. doi:10.1002/pon.570.CrossRef

47.

Holzner B, Kemmler G, Kopp M, Moschen R, Schweigkofler H, Dunser M, et al. Quality of life in breast cancer patients–not enough attention for long-term survivors? Psychosomatics. 2001;42(2):117–23.PubMedCrossRef

48.

Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psycho Oncol. 2002;11(2):142–53. doi:10.1002/pon.567.CrossRef

49.

Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol. 2006;100(3):479–86. doi:10.1016/j.ygyno.2005.08.023.PubMedCrossRef

50.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Heal Soc Behav. 1983;24:385–96.CrossRef

51.

Cohen S, Williamson G. Perceived stress in a probability sample of the U.S. In: Oskamp SSS, editor. The social psychology of health: Claremont Symposium on Applied Social Psychology. Newbury Park: Sage; 1988.

52.

Branstrom R, Kvillemo P, Brandberg Y, Moskowitz JT. Self-report mindfulness as a mediator of psychological well-being in a stress reduction intervention for cancer patients–a randomized study. Ann Behav Med. 2010;39(2):151–61. doi:10.1007/s12160-010-9168-6.PubMedCrossRef

53.

Radloff L. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef

54.

Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Canc Inst. 2002;94(1):39–49.CrossRef

55.

Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21(22):4184–93. doi:10.1200/JCO.2003.04.196.PubMedCrossRef

56.

Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–18.PubMed

57.

Andersen BL, Farrar WB, Golden-Kreutz D, Kutz LA, MacCallum R, Courtney ME, et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Canc Inst. 1998;90(1):30–6.CrossRef

58.

Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13(1):27–45. doi:10.1177/1073191105283504.PubMedCrossRef

59.

Neff KD. Development and validation of a scale to measure self-compassion. Self Ident. 2003;2:223–50.CrossRef

60.

Birnie K, Garland SN, Carlson LE. Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR). Psycho Oncol. 2010;19(9):1004–9. doi:10.1002/pon.1651.CrossRef

61.

Forti A. Mindfulness and quality of life among breast cancer survivors: the mediating role of self-kindness and alexithymia. Ph.D. thesis; 2011.

62.

Henkel V, Mergl R, Kohnen R, Maier W, Moller HJ, Hegerl U. Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ. 2003;326(7382):200–1.PubMedCrossRef

63.

Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res. 2003;12(2):85–91.PubMedCrossRef

64.

Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70.PubMedCrossRef

65.

Watson D, Clark LA. The PANAS-X: manual for the positive and negative affect schedule—expanded form. Iowa City: University of Iowa; 1994.

66.

Bellizzi KM, Blank TO. Cancer-related identity and positive affect in survivors of prostate cancer. J Canc Surviv. 2007;1(1):44–8. doi:10.1007/s11764-007-0005-2.CrossRef

67.

Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med. 1992;11(13):1685–704.PubMedCrossRef

68.

Edwards LJ, Muller KE, Wolfinger RD, Qaqish BF, Schabenberger O. An R2 statistic for fixed effects in the linear mixed model. Stat Med. 2008;27(29):6137–57. doi:10.1002/sim.3429.PubMedCrossRef

69.

Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79. doi:10.1186/1477-7525-1-79.PubMedCrossRef

70.

Lengacher CA, Johnson-Mallard V, Barta M, Fitzgerald S, Moscoso MS, Post-White J, et al. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2011;29(2):107–17. doi:10.1177/0898010110385938.PubMedCrossRef

71.

Edinger JD, Olsen MK, Stechuchak KM, Means MK, Lineberger MD, Kirby A, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. Sleep. 2009;32(4):499–510.PubMed

72.

Edinger JD, Wohlgemuth WK, Radtke RA, Coffman CJ, Carney CE. Dose–response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep. 2007;30(2):203–12.PubMed

73.

Carmody J, Baer RA. How long does a mindfulness-based stress reduction program need to be? A review of class contact hours and effect sizes for psychological distress. J Clin Psychol. 2009;65(6):627–38. doi:10.1002/jclp.20555.PubMedCrossRef

74.

Britton WB, Bootzin RR, Cousins JC, Hasler BP, Peck T, Shapiro SL. The contribution of mindfulness practice to a multicomponent behavioral sleep intervention following substance abuse treatment in adolescents: a treatment-development study. Subst Abus. 2010;31(2):86–97. doi:10.1080/08897071003641297.PubMedCrossRef

75.

Heidenreich T, Tuin I, Pflug B, Michal M, Michalak J. Mindfulness-based cognitive therapy for persistent insomnia: a pilot study. Psychother Psychosom. 2006;75(3):188–9. doi:10.1159/000091778.PubMedCrossRef

76.

Ong JC, Shapiro SL, Manber R. Combining mindfulness meditation with cognitive-behavior therapy for insomnia: a treatment-development study. Behav Ther. 2008;39(2):171–82. doi:10.1016/j.beth.2007.07.002.PubMedCrossRef

77.

Ong JC, Shapiro SL, Manber R. Mindfulness meditation and cognitive behavioral therapy for insomnia: a naturalistic 12-month follow-up. Explore (NY). 2009;5(1):30–6. doi:10.1016/j.explore.2008.10.004.CrossRef

78.

Yook K, Lee SH, Ryu M, Kim KH, Choi TK, Suh SY, et al. Usefulness of mindfulness-based cognitive therapy for treating insomnia in patients with anxiety disorders: a pilot study. J Nerv Ment Dis. 2008;196(6):501–3. doi:10.1097/NMD.0b013e31817762ac.PubMedCrossRef

79.

Garland SN, Carlson LE, Antle MC, Samuels C, Campbell T. I-CAN SLEEP: rationale and design of a non-inferiority RCT of mindfulness-based stress reduction and cognitive behavioral therapy for the treatment of insomnia in cancer survivors. Contemp Clin Trials. 2011;32(5):747–54. doi:10.1016/j.cct.2011.05.014.PubMedCrossRef

Title: Investigating efficacy of two brief mind–body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial
Authors: Yoshio Nakamura
David L. Lipschitz
Renee Kuhn
Anita Y. Kinney
Gary W. Donaldson
Publication date: 01-06-2013
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 2/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-012-0252-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 2/2013

Effectiveness of treatment summaries in increasing breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment

Brief self-report measure of work-related cognitive limitations in breast cancer survivors

The association between television watching time and all-cause mortality after breast cancer

Long-term breast cancer survivors’ symptoms and morbidity: differences by sexual orientation?

Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?

Time away from work: employed husbands of women treated for breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer